South Africa says J&J, Pfizer, Moderna vaccines in group for 'immediate use'
JOHANNESBURG (Reuters) - South Africa's health minister said on Tuesday that a committee advising the government had grouped COVID-19 vaccines into three groups and those considered for "immediate use" were the Johnson & Johnson, Pfizer and Moderna shots.
In a second group where South Africa is interested but requires more technical information are Russia's Sputnik V vaccine and shots from China's Sinopharm and Sinovac, Health Minister Zweli Mkhize said.
A third group where vaccines "may not be suitable for immediate use in South Africa" includes the AstraZeneca and Novavax vaccines, Mkhize added.
(Reporting by Alexander Winning; Editing by Promit Mukherjee)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.